Luzak B, Golanski J, Rozalski M
Int J Mol Sci. 2025; 26(1.
PMID: 39795908
PMC: 11719713.
DOI: 10.3390/ijms26010049.
Menezes F, da Fonseca Palmeira J, Oliveira J, Arganaraz G, Soares C, Nobrega O
Front Cell Neurosci. 2025; 18:1481963.
PMID: 39744674
PMC: 11688492.
DOI: 10.3389/fncel.2024.1481963.
Roytenberg R, Yue H, DeHart A, Kim E, Bai F, Kim Y
Thromb Res. 2024; 244:109195.
PMID: 39442286
PMC: 11585440.
DOI: 10.1016/j.thromres.2024.109195.
Swank Z, Borberg E, Chen Y, Senussi Y, Chalise S, Manickas-Hill Z
Clin Microbiol Infect. 2024; 30(12):1599-1605.
PMID: 39389851
PMC: 11578795.
DOI: 10.1016/j.cmi.2024.09.001.
Franco C, Cornejo A, Rodriguez M, Garcia A, Belisario I, Mayora S
Viruses. 2024; 16(9).
PMID: 39339956
PMC: 11437404.
DOI: 10.3390/v16091480.
Myocarditis associated with COVID-19 vaccination.
Buoninfante A, Andeweg A, Genov G, Cavaleri M
NPJ Vaccines. 2024; 9(1):122.
PMID: 38942751
PMC: 11213864.
DOI: 10.1038/s41541-024-00893-1.
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Marquez-Martinez S, Khan S, Lubbe J, Solforosi L, Costes L, Choi Y
Vaccines (Basel). 2024; 12(5).
PMID: 38793810
PMC: 11126103.
DOI: 10.3390/vaccines12050559.
Differential Cytokine Responses of APOE3 and APOE4 Blood-brain Barrier Cell Types to SARS-CoV-2 Spike Proteins.
Chaves J, Milton L, Stewart R, Senapati T, Rantanen L, Wasielewska J
J Neuroimmune Pharmacol. 2024; 19(1):22.
PMID: 38771543
DOI: 10.1007/s11481-024-10127-9.
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.
Scheim D, Parry P, Rabbolini D, Aldous C, Yagisawa M, Clancy R
Viruses. 2024; 16(4).
PMID: 38675987
PMC: 11054389.
DOI: 10.3390/v16040647.
Impact of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review.
Bocquet-Garcon A
Cureus. 2024; 16(3):e57008.
PMID: 38549864
PMC: 10973921.
DOI: 10.7759/cureus.57008.
Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies.
Heil M
Front Immunol. 2024; 14:1259879.
PMID: 38439942
PMC: 10910434.
DOI: 10.3389/fimmu.2023.1259879.
The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders.
Ayyubova G, Gychka S, Nikolaienko S, Alghenaim F, Teramoto T, Shults N
Life (Basel). 2024; 14(2).
PMID: 38398788
PMC: 10890058.
DOI: 10.3390/life14020279.
The mRNA-LNP vaccines - the good, the bad and the ugly?.
Igyarto B, Qin Z
Front Immunol. 2024; 15:1336906.
PMID: 38390323
PMC: 10883065.
DOI: 10.3389/fimmu.2024.1336906.
Cardiac Involvement in Patients With Multisystem Inflammatory Syndrome in Adults.
La Vecchia G, Del Buono M, Bonaventura A, Vecchie A, Moroni F, Cartella I
J Am Heart Assoc. 2024; 13(4):e032143.
PMID: 38348793
PMC: 11010102.
DOI: 10.1161/JAHA.123.032143.
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination.
Nziza N, Deng Y, Wood L, Dhanoa N, Dulit-Greenberg N, Chen T
Nat Commun. 2024; 15(1):905.
PMID: 38291080
PMC: 10827750.
DOI: 10.1038/s41467-024-45181-7.
Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies.
Pateev I, Seregina K, Ivanov R, Reshetnikov V
Biomedicines. 2024; 12(1).
PMID: 38255166
PMC: 10812935.
DOI: 10.3390/biomedicines12010059.
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis.
Angues R, Perea Bustos Y
Cureus. 2024; 15(12):e50703.
PMID: 38234925
PMC: 10792266.
DOI: 10.7759/cureus.50703.
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits.
Khan S, Marquez-Martinez S, Erkens T, de Wilde A, Costes L, Vinken P
Vaccines (Basel). 2023; 11(12).
PMID: 38140195
PMC: 10747520.
DOI: 10.3390/vaccines11121792.
SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes.
Okuno S, Higo S, Kondo T, Shiba M, Kameda S, Inoue H
Sci Rep. 2023; 13(1):21397.
PMID: 38049441
PMC: 10696029.
DOI: 10.1038/s41598-023-48084-7.
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.
Puhach O, Bellon M, Adea K, Bekliz M, Hosszu-Fellous K, Sattonnet P
EBioMedicine. 2023; 98:104893.
PMID: 38035462
PMC: 10755109.
DOI: 10.1016/j.ebiom.2023.104893.
